Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Kyowa Pharma Joins Forces with German neuroCare Group in CNS
April 8, 2020
- Pfizer Japan Extends Work-from-Home through May 6
April 7, 2020
- Takeda, CSL, Other Firms Join Hands to Develop Unbranded Immunoglobulin for COVID-19
April 7, 2020
- MSD Japan to Get Women’s Health Spinoff Organon Up and Running in October: Chief
April 7, 2020
- Japan Ethical Drug Sales Up 3.4% in FY2019: Encise
April 7, 2020
- Rush to BCG Vaccine for COVID-19 Leads to Curbs on Shipments
April 7, 2020
- Kowa Sues Towa Again over Livalo Generics, Seeking Over 4.8 Billion Yen in Additional Damages for FY2017
April 7, 2020
- Astellas, Bandai Namco Link Up on Codevelopment of Exercise Support App
April 7, 2020
- Meiji Scoops Up Marketing Rights for Mochida’s Epadel in Vietnam
April 7, 2020
- Fujifilm Wako to Launch Coronavirus Test on April 15
April 6, 2020
- Sumitomo Dainippon, Ehime Univ. Aim to Make New Malaria Vaccine IND-Ready by March 2022
April 6, 2020
- Big 3 Generic Maker Curbing Valsartan Shipments amid India Lockdown
April 6, 2020
- Japan Generic Market Crosses 1 Trillion Yen Mark in 2019: Fuji Keizai
April 6, 2020
- Denka to Resume Production of Compound for Avigan
April 3, 2020
- Alfresa Allies with Cell Therapy Startup; Possible Tripartite Collaboration with Rohto
April 3, 2020
- Takeda Launches Dedicated COVID-19 Website to Inform of Product Supply, R&D Status
April 3, 2020
- Eisai, Seikagaku Pair Up for Osteoarthritis Drug in China
April 2, 2020
- Amgen Kicks Off Stand-Alone Biz in Japan, Eyes Simultaneous Launch of Full Pipeline
April 2, 2020
- Pfizer Pausing Global Trial Recruitments, but Not in Japan
April 2, 2020
- Daiichi Sankyo Gets License to Ultragenyx’s Gene Therapy Manufacturing Techs
April 2, 2020
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…